01.01.25
In today’s episode, we review the top stories from the second half of 2024. The last six months saw the launch of first-of-its-kind IOLS; the clinical advancement of gene therapies for rare diseases; the FDA approval of a device to treat patients with dry AMD; and introduction of novel OCTA technology. Learn more about your ad choices. Visit megaphone.fm/adchoices
View full description +
Subscribe
07.30.25
Tryptyr Now Available in US07.16.25
AECOS Presentation SummariesShow More